Dublin, Ireland & Cleveland, Ohio – January 27, 2025—Kitman Labs, the global leader in human performance intelligence, and NeuroLogix Technologies, the developer of the C3Logix brain health platform, today announced a new integration that brings C3Logix’s validated neurological assessment and concussion management capabilities to Kitman Labs’ iP: Intelligence Platform and the Performance Medicine Solution.
This collaboration establishes the industry’s first fully connected brain health intelligence system, combining validated neurological testing with comprehensive medical, performance, and operational data. The result is a unified, data-driven environment designed to help sports organizations deliver safer, more consistent, and evidence-based care to athletes across their careers.
A Unified Approach to Brain Health
Through this integration, practitioners can conduct neurologic performance assessments, including processing speed, executive function, balance and reaction tests, as well as symptom tracking using C3Logix, with all results automatically synchronized to the athlete’s medical record within Kitman Labs’ iP: Intelligence Platform.
This connected workflow allows medical and performance teams to view neurological data alongside injury history, wellness metrics, and workload trends — creating a more complete picture of athlete health and recovery.
“Brain health can’t be managed in isolation,” said Stephen Smith, Founder and CEO of Kitman Labs. “By integrating C3Logix within our iP: Intelligence Platform, we’re enabling practitioners and organizations to connect neurological data directly to the broader context of player health and performance. It’s about smarter decision-making, consistent protocols, and better long-term outcomes for athletes.”
Bringing Clinical Precision and Data Intelligence Together
C3Logix assessment modules were clinically validated at the Cleveland Clinic, and its brain health assessment and concussion management system is used by professional, collegiate, and youth sports organizations worldwide to manage concussions, as well as review year over year brain health performance changes in the absence of diagnosed concussion.
Its core capabilities—including neurocognitive and neuromotor assessments with sensor-based balance and reaction testing, baseline and post-injury comparisons, and recovery tracking—are now available within Kitman Labs’ integrated ecosystem, already trusted by leagues and federations across global sport. C3Logix’s flexible workflows allow you to digitize your entire concussion management policy while using standard protocols like SCAT6/SCOAT6 or specifying your own.
“This integration gives medical and performance professionals a unified system that mirrors how care is actually delivered in sport,” said Frank Carruba, CEO of NeuroLogix Technologies. “C3Logix delivers the clinical precision needed to assess and manage concussion, while Kitman Labs provides the intelligence platform that connects those insights across teams and organizations. Together, we’re creating a more connected, informed, and proactive approach to brain health in sport.”
Benefits Across the Sports Ecosystem
- For Athletes: A single, longitudinal record of brain health supports faster, evidence-based recovery and consistent care throughout their careers.
- For Practitioners: Integrated workflows eliminate system switching and manual entry, combining validated neurological tools with medical and performance data for more informed decision-making.
- For Organizations: Unified oversight enables standardization of concussion protocols, transparent reporting, and long-term intelligence to support compliance and player welfare.
Moving Toward a Proactive Brain Health Strategy
The integration of C3Logix in Kitman Labs’ iP: Intelligence Platform enables sports organizations to move from reactive concussion management to a proactive brain health model—where clinical precision, operational efficiency, and data-driven insight converge.
“This partnership represents the next evolution of connected care in sport,” added Stephen Smith of Kitman Labs. “When validated clinical tools are directly integrated into the same system that manages performance and medical data, organizations gain both clarity and capability—the ability to make decisions that protect players and enhance performance at the same time.”
Availability
The integrated C3Logix capability is available immediately within Kitman Labs’ Performance Medicine Solution, part of the company’s multi-solution Intelligence Platform, used by elite teams, leagues, and governing bodies worldwide.
About Kitman Labs
Kitman Labs is the world’s leading sports science and Performance Intelligence Company. Kitman Labs powers iP: Intelligence Platform, the advanced operating system used by the largest and most innovative leagues, teams and regulatory bodies in elite Sport and Defense. Our software solutions – Performance Medicine, Performance Optimization, Coaching & Development and League Operations – have been designed to optimise human performance; enhance overall health, wellness and longevity; reduce injury risk; and drive operational efficiencies and value. Kitman Labs is headquartered in Silicon Valley and Dublin.
About NeuroLogix
NeuroLogix is a technology company focused on advancing brain health through innovation and evidence-based tools. Its flagship product, C3Logix, is a clinically validated, mobile-based system for concussion assessment and management. Used globally by sports organizations, universities, and healthcare providers, C3Logix enables consistent, objective, and data-driven evaluation of neurological function to support safe return-to-play and long-term brain health.
Visit www.C3Logix.com.
Media Contact:
Kitman Labs
The PHA Group
kitmanlabs@thephagroup.com
NeuroLogix (TBC)
info@C3Logix.com
www.C3Logix.com
